We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Genetic Variation Associated with Alcoholic Liver Disease

By LabMedica International staff writers
Posted on 05 Jan 2011
Genotyping has revealed that gene variation is strongly linked with cirrhosis of the liver and elevated transaminase levels in alcoholic Caucasians. More...


Blood tests for liver enzymes and genotyping of patients' DNA pinpoint the risk and susceptibility to progress towards alcoholic liver disease in those who drink excessive amounts of alcohol, which may be fatal.

Scientists from the University of Bern (Bern, Switzerland) and the Christian-Albrechts-University (Kiel, Germany) determined the genotype and allele frequencies of the adiponutrin or patatin-like phospholipase (PNPLA3) gene. Adiponutrin a transmembrane protein specifically expressed in adipose tissue. Participants in the study included 1,043 alcoholics with or without alcoholic liver injury and in 376 at-risk drinkers from a population-based cohort.

Cirrhosis and steatosis (fatty liver) were determined by liver biopsy and standard diagnostic testing. The liver enzymes alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels in the serum of the participants were established using routine clinical chemistry testing. Participants were categorized as alcoholic liver cirrhosis (ALC); alcoholics with liver steatosis on ultrasound and elevation of ALT as alcoholic liver damage (ALD); alcoholic liver steatosis and normal liver enzyme levels as alcoholic fatty liver (AFL); and alcoholics with normal appearance of the liver on ultrasound and normal liver enzyme levels as alcoholic controls.

The results of the study showed that single nucleotide polymorphism (SNP) rs738409 was strongly over-represented in patients with ALC and ALD compared to alcoholics without liver damage. Additionally, the frequency of allele PNPLA3 rs738409 in AFL participants was lower than in alcoholics without steatosis and normal liver enzymes. The gene was associated with cirrhosis of the liver and elevated transaminase levels in alcoholic Caucasians.

Jochen Hampe, MD, the lead author, concluded that carriers with the genetic variation, PNPLA3 rs738409, represent a subpopulation of high-risk individuals susceptible to progression from clinically silent alcoholic liver disease to obvious cirrhosis. The study was published online December 7, 2010, in Hepatology.

Related Links:

University of Bern
Christian-Albrechts-University



Gold Member
Troponin T QC
Troponin T Quality Control
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automated Biochemical Analyzer
iBC 900
New
Hand-Held Immunofluorescence Analyzer
WS-Si1500
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.